vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and Consolidated Edison (ED). Click either name above to swap in a different company.

Consolidated Edison is the larger business by last-quarter revenue ($4.0M vs $2.8M, roughly 1.4× DBV Technologies S.A.). On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs 8.9%). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs -96.5%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Consolidated Edison, Inc., commonly known as Con Edison or ConEd, is an energy company based in New York City. It is one of the largest investor-owned energy companies in the United States, with approximately $15.26 billion in annual revenues as of 2024, and over $70 billion in assets. The company provides a wide range of energy-related products and services to its customers through its subsidiaries:Consolidated Edison Company of New York, Inc.

DBVT vs ED — Head-to-Head

Bigger by revenue
ED
ED
1.4× larger
ED
$4.0M
$2.8M
DBVT
Growing faster (revenue YoY)
DBVT
DBVT
+149.9% gap
DBVT
158.8%
8.9%
ED
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
-96.5%
ED

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
DBVT
DBVT
ED
ED
Revenue
$2.8M
$4.0M
Net Profit
$-33.2M
Gross Margin
Operating Margin
-1235.7%
12.2%
Net Margin
-1195.5%
Revenue YoY
158.8%
8.9%
Net Profit YoY
-8.9%
EPS (diluted)
$-0.24
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
ED
ED
Q1 26
$4.0M
Q4 25
$4.0B
Q3 25
$2.8M
$4.6B
Q2 25
$1.5M
$3.6B
Q1 25
$4.9B
Q4 24
$3.7B
Q3 24
$4.2B
Q2 24
$1.2M
$3.3B
Net Profit
DBVT
DBVT
ED
ED
Q1 26
Q4 25
$298.0M
Q3 25
$-33.2M
$688.0M
Q2 25
$-41.9M
$246.0M
Q1 25
$791.0M
Q4 24
$310.0M
Q3 24
$588.0M
Q2 24
$-33.1M
$202.0M
Operating Margin
DBVT
DBVT
ED
ED
Q1 26
12.2%
Q4 25
12.3%
Q3 25
-1235.7%
21.2%
Q2 25
-2806.2%
9.8%
Q1 25
23.0%
Q4 24
13.0%
Q3 24
20.4%
Q2 24
-2914.9%
9.7%
Net Margin
DBVT
DBVT
ED
ED
Q1 26
Q4 25
7.5%
Q3 25
-1195.5%
15.1%
Q2 25
-2858.4%
6.8%
Q1 25
16.2%
Q4 24
8.5%
Q3 24
13.9%
Q2 24
-2852.4%
6.1%
EPS (diluted)
DBVT
DBVT
ED
ED
Q1 26
$0.82
Q4 25
$0.81
Q3 25
$-0.24
$1.90
Q2 25
$-0.31
$0.68
Q1 25
$2.25
Q4 24
$0.89
Q3 24
$1.69
Q2 24
$-0.34
$0.58

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
ED
ED
Cash + ST InvestmentsLiquidity on hand
$69.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$52.9M
Total Assets
$110.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
ED
ED
Q1 26
Q4 25
$1.6B
Q3 25
$69.8M
$181.0M
Q2 25
$103.2M
$1.5B
Q1 25
$360.0M
Q4 24
$1.3B
Q3 24
$93.0M
Q2 24
$66.2M
$1.5B
Total Debt
DBVT
DBVT
ED
ED
Q1 26
Q4 25
$25.8B
Q3 25
Q2 25
Q1 25
Q4 24
$24.7B
Q3 24
Q2 24
Stockholders' Equity
DBVT
DBVT
ED
ED
Q1 26
Q4 25
$24.2B
Q3 25
$52.9M
$24.2B
Q2 25
$86.2M
$23.8B
Q1 25
$23.8B
Q4 24
$22.0B
Q3 24
$21.9B
Q2 24
$79.1M
$21.6B
Total Assets
DBVT
DBVT
ED
ED
Q1 26
Q4 25
$74.6B
Q3 25
$110.5M
$71.8B
Q2 25
$143.4M
$71.5B
Q1 25
$70.7B
Q4 24
$70.6B
Q3 24
$68.6B
Q2 24
$114.2M
$67.9B
Debt / Equity
DBVT
DBVT
ED
ED
Q1 26
Q4 25
1.07×
Q3 25
Q2 25
Q1 25
Q4 24
1.13×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
ED
ED
Operating Cash FlowLast quarter
$-32.4M
Free Cash FlowOCF − Capex
$-32.6M
FCF MarginFCF / Revenue
-1173.5%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
ED
ED
Q1 26
Q4 25
$1.5B
Q3 25
$-32.4M
$504.0M
Q2 25
$-33.9M
$2.0B
Q1 25
$837.0M
Q4 24
$1.3B
Q3 24
$392.0M
Q2 24
$-35.1M
$1.3B
Free Cash Flow
DBVT
DBVT
ED
ED
Q1 26
Q4 25
Q3 25
$-32.6M
Q2 25
$-33.9M
Q1 25
Q4 24
Q3 24
Q2 24
$-35.8M
FCF Margin
DBVT
DBVT
ED
ED
Q1 26
Q4 25
Q3 25
-1173.5%
Q2 25
-2316.5%
Q1 25
Q4 24
Q3 24
Q2 24
-3084.0%
Capex Intensity
DBVT
DBVT
ED
ED
Q1 26
Q4 25
Q3 25
4.2%
Q2 25
2.2%
Q1 25
Q4 24
Q3 24
Q2 24
63.0%
Cash Conversion
DBVT
DBVT
ED
ED
Q1 26
Q4 25
4.97×
Q3 25
0.73×
Q2 25
8.04×
Q1 25
1.06×
Q4 24
4.23×
Q3 24
0.67×
Q2 24
6.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DBVT
DBVT

Segment breakdown not available.

ED
ED

Electric$2.9M72%
Gas$923.0K23%
Other$187.0K5%
Non-utility$1.0K0%

Related Comparisons